A citation-based method for searching scientific literature

Valentina Calò, Loredana Bruno, Laura La Paglia, Marco Perez, Naomi Margarese, Francesca Di Gaudio, Antonio Russo. Cancers (Basel) 2010
Times Cited: 21

List of co-cited articles
64 articles co-cited >1

Times Cited
  Times     Co-cited

Unclassified variants in BRCA genes: guidelines for interpretation.
P Radice, S De Summa, L Caleca, S Tommasi. Ann Oncol 2011

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.
Myong Cheol Lim, Sokbom Kang, Sang-Soo Seo, Sun-Young Kong, Bo-Yon Lee, Seon-Kyung Lee, Sang-Yoon Park. J Cancer Res Clin Oncol 2009

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

A method and server for predicting damaging missense mutations.
Ivan A Adzhubei, Steffen Schmidt, Leonid Peshkin, Vasily E Ramensky, Anna Gerasimova, Peer Bork, Alexey S Kondrashov, Shamil R Sunyaev. Nat Methods 2010

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Eunyoung Kang, Moon-Woo Seong, Sue K Park, Jong Won Lee, Jihyoun Lee, Lee Su Kim, Jeong Eon Lee, Sung Yong Kim, Joon Jeong, Sang Ah Han,[...]. Breast Cancer Res Treat 2015

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients.
Kyung Jin Eoh, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Jeongwoo Han, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Eun Ji Nam. Cancer Res Treat 2017

Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea.
Jai Min Ryu, Goeun Kang, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Se Kyung Lee, Soo Youn Bae, Sungmin Park, Hyun-June Paik, Jong-Won Kim,[...]. Breast 2017

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008

Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.
Kaylene Ready, Angelica M Gutierrez-Barrera, Christopher Amos, Funda Meric-Bernstam, Karen Lu, Gabriel Hortobagyi, Banu Arun. Breast J 2011

The influence of BRCA variants of unknown significance on cancer risk management decision-making.
Jing Yi Chern, Sarah S Lee, Melissa K Frey, Jessica Lee, Stephanie V Blank. J Gynecol Oncol 2019

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
D M Eccles, G Mitchell, A N A Monteiro, R Schmutzler, F J Couch, A B Spurdle, E B Gómez-García. Ann Oncol 2015

BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
Noralane M Lindor, David E Goldgar, Sean V Tavtigian, Sharon E Plon, Fergus J Couch. Oncologist 2013

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
Leila Mohammadi, Maaike P Vreeswijk, Rogier Oldenburg, Ans van den Ouweland, Jan C Oosterwijk, Annemarie H van der Hout, Nicoline Hoogerbrugge, Marjolijn Ligtenberg, Margreet G Ausems, Rob B van der Luijt,[...]. BMC Cancer 2009

Classifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios.
Rachel Karchin, Mukesh Agarwal, Andrej Sali, Fergus Couch, Mary S Beattie. Cancer Inform 2008

Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.
Andrew D Spearman, Kevin Sweet, Xiao-Ping Zhou, Jane McLennan, Fergus J Couch, Amanda Ewart Toland. J Clin Oncol 2008

Predicting functional effect of human missense mutations using PolyPhen-2.
Ivan Adzhubei, Daniel M Jordan, Shamil R Sunyaev. Curr Protoc Hum Genet 2013

ClinVar: public archive of relationships among sequence variation and human phenotype.
Melissa J Landrum, Jennifer M Lee, George R Riley, Wonhee Jang, Wendy S Rubinstein, Deanna M Church, Donna R Maglott. Nucleic Acids Res 2014

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.
C Sue Richards, Sherri Bale, Daniel B Bellissimo, Soma Das, Wayne W Grody, Madhuri R Hegde, Elaine Lyon, Brian E Ward. Genet Med 2008

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012

Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.
S V Tavtigian, A M Deffenbaugh, L Yin, T Judkins, T Scholl, P B Samollow, D de Silva, A Zharkikh, A Thomas. J Med Genet 2006

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout, Margreet G E M Ausems. Genet Med 2007

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009

Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.
Min Chul Choi, Jin-Hyung Heo, Ja-Hyun Jang, Sang Geun Jung, Hyun Park, Won Duk Joo, Chan Lee, Je Ho Lee, Jun Mo Lee, Yoon Young Hwang,[...]. Int J Gynecol Cancer 2015

The contribution of BRCA1 and BRCA2 to ovarian cancer.
Susan J Ramus, Simon A Gayther. Mol Oncol 2009

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
H Aida, K Takakuwa, H Nagata, I Tsuneki, M Takano, S Tsuji, T Takahashi, T Sonoda, M Hatae, K Takahashi,[...]. Clin Cancer Res 1998

Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma.
Young Tae Kim, Eun Ji Nam, Bo Sung Yoon, Sang Wun Kim, Sung Hoon Kim, Jae Hoon Kim, Hyun Ki Kim, Ja Seong Koo, Jae Wook Kim. Gynecol Oncol 2005

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen,[...]. JAMA 2005

The breast cancer information core: database design, structure, and scope.
C Szabo, A Masiello, J F Ryan, L C Brody. Hum Mutat 2000

Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.
Yanfeng Zhang, Jirong Long, Wei Lu, Xiao-Ou Shu, Qiuyin Cai, Ying Zheng, Chun Li, Bingshan Li, Yu-Tang Gao, Wei Zheng. Cancer Epidemiol Biomarkers Prev 2014

BRCA1 mutations in primary breast and ovarian carcinomas.
P A Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, S Tavtigian, L M Bennett, A Haugen-Strano, J Swensen, Y Miki. Science 1994

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
Ake Borg, Robert W Haile, Kathleen E Malone, Marinela Capanu, Ahn Diep, Therese Törngren, Sharon Teraoka, Colin B Begg, Duncan C Thomas, Patrick Concannon,[...]. Hum Mutat 2010

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients.
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee. Cancer Res Treat 2017

Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing.
Vanessa Lattimore, Margaret Currie, Caroline Lintott, Jan Sullivan, Bridget A Robinson, Logan C Walker. N Z Med J 2015

Structure-Function Of The Tumor Suppressor BRCA1.
Serena L Clark, Ana M Rodriguez, Russell R Snyder, Gary D V Hankins, Darren Boehning. Comput Struct Biotechnol J 2012

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005

Accurate classification of BRCA1 variants with saturation genome editing.
Gregory M Findlay, Riza M Daza, Beth Martin, Melissa D Zhang, Anh P Leith, Molly Gasperini, Joseph D Janizek, Xingfan Huang, Lea M Starita, Jay Shendure. Nature 2018

Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
C Bonnet, S Krieger, M Vezain, A Rousselin, I Tournier, A Martins, P Berthet, A Chevrier, C Dugast, V Layet,[...]. J Med Genet 2008

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.